These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 28714400

  • 1. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB, Talhi O, Silva ASM, Senol FS, Orhan IE, Rauf A, Mabkhot YN, Bachari K, Warad I, Farghaly TA, Althagafi II, Mubarak MS.
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [Abstract] [Full Text] [Related]

  • 2. Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies.
    Hadda TB, Deniz FSS, Orhan IE, Zgou H, Rauf A, Mabkhot YN, Bennani B, Emam DR, Kheder NA, Asayari A, Muhsinah AB, Maalik A.
    Med Chem; 2021; 17(8):834-843. PubMed ID: 32520690
    [Abstract] [Full Text] [Related]

  • 3. Drug Design of Inhibitors of Alzheimer's Disease (AD): POM and DFT Analyses of Cholinesterase Inhibitory Activity of β-amino di-Carbonyl Derivatives.
    Hadda TB, Rauf A, Zgou H, Senol FS, Orhan IE, Mabkhot YN, Althagafi II, Farghaly TA, Alterary S.
    Mini Rev Med Chem; 2019; 19(8):688-705. PubMed ID: 30387392
    [Abstract] [Full Text] [Related]

  • 4. Ionic liquid mediated synthesis of mono- and bis-spirooxindole-hexahydropyrrolidines as cholinesterase inhibitors and their molecular docking studies.
    Kia Y, Osman H, Kumar RS, Basiri A, Murugaiyah V.
    Bioorg Med Chem; 2014 Feb 15; 22(4):1318-28. PubMed ID: 24461561
    [Abstract] [Full Text] [Related]

  • 5. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
    Iqbal J, Abbasi MSA, Zaib S, Afridi S, Furtmann N, Bajorath J, Langer P.
    Med Chem; 2018 Feb 15; 14(8):809-817. PubMed ID: 29473519
    [Abstract] [Full Text] [Related]

  • 6. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A, Zehra ST, Shah SJ, Khan KM, Alharthy RD, Furtmann N, Bajorath J, Tahir MN, Iqbal J.
    Chem Biol Drug Des; 2015 Nov 15; 86(5):1115-20. PubMed ID: 25951978
    [Abstract] [Full Text] [Related]

  • 7. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
    Rehman TU, Khan IU, Ashraf M, Tarazi H, Riaz S, Yar M.
    Arch Pharm (Weinheim); 2017 Apr 15; 350(3-4):. PubMed ID: 28220522
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA, Shah MS, Saeed A, Khan SU, Larik FA, Shabir G, Iqbal J.
    Med Chem; 2017 Apr 15; 13(7):648-653. PubMed ID: 28266279
    [Abstract] [Full Text] [Related]

  • 9. In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes.
    Al-Aboudi A, Al-Qawasmeh RA, Shahwan A, Mahmood U, Khalid A, Ul-Haq Z.
    Acta Pharmacol Sin; 2015 Jul 15; 36(7):879-86. PubMed ID: 25937631
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA, Ali MY, Jung HJ, Jeong HO, Chung HY, Choi JS.
    J Ethnopharmacol; 2016 Sep 15; 191():152-160. PubMed ID: 27321278
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines.
    Basiri A, Abd Razik BM, Ezzat MO, Kia Y, Kumar RS, Almansour AI, Arumugam N, Murugaiyah V.
    Bioorg Chem; 2017 Dec 15; 75():210-216. PubMed ID: 28987876
    [Abstract] [Full Text] [Related]

  • 12. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec 15; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 13. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H, Jiang Y, Zhan J, Sun Y.
    Bioorg Chem; 2021 Sep 15; 114():105149. PubMed ID: 34252860
    [Abstract] [Full Text] [Related]

  • 14. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B, Gulcan HO, Aksakal F, Ercetin T, Oruklu N, Umit Bagriacik E, Dogruer DS.
    Bioorg Chem; 2018 Sep 15; 79():235-249. PubMed ID: 29775949
    [Abstract] [Full Text] [Related]

  • 15. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
    Orhan IE, Jedrejek D, Senol FS, Salmas RE, Durdagi S, Kowalska I, Pecio L, Oleszek W.
    Phytomedicine; 2018 Mar 15; 42():25-33. PubMed ID: 29655693
    [Abstract] [Full Text] [Related]

  • 16. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU, Sadiq A, Ashraf J, Zafar MN, Sumrra SH, Tariq R, Mumtaz A, Javid A, Khan BA, Ali A, Javed CO.
    Bioorg Chem; 2019 Oct 15; 91():103124. PubMed ID: 31319297
    [Abstract] [Full Text] [Related]

  • 17. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile.
    Makhaeva GF, Kovaleva NV, Boltneva NP, Rudakova EV, Lushchekina SV, Astakhova TY, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Korabecny J, Soukup O, Bachurin SO, Richardson RJ.
    Molecules; 2022 Feb 04; 27(3):. PubMed ID: 35164325
    [Abstract] [Full Text] [Related]

  • 18. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS, Khan SU, Ejaz SA, Afridi S, Rizvi SUF, Najam-Ul-Haq M, Iqbal J.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):615-624. PubMed ID: 27865835
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors.
    Kia Y, Osman H, Suresh Kumar R, Basiri A, Murugaiyah V.
    Bioorg Med Chem Lett; 2014 Apr 01; 24(7):1815-9. PubMed ID: 24594354
    [Abstract] [Full Text] [Related]

  • 20. A facile chemo-, regio- and stereoselective synthesis and cholinesterase inhibitory activity of spirooxindole-pyrrolizine-piperidine hybrids.
    Kia Y, Osman H, Kumar RS, Murugaiyah V, Basiri A, Perumal S, Razak IA.
    Bioorg Med Chem Lett; 2013 May 15; 23(10):2979-83. PubMed ID: 23570788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.